Hospira, Inc. issued a nationwide recall on four of its injectable cancer drugs. They include Carboplatin, Cytarabine, Paclitaxel, and Methotrexate.
There is concern injury could result if the solution were injected into a patient.
The company is blaming the supplier for the glass defect problem.